Skip to Content
Stock Analyst Update

UnitedHealth Results In-Line With Expectations

We are reiterating our fair value estimate and narrow moat rating for the managed-care firm.


There were no major surprises for  UnitedHealth (UNH) during its second quarter, and we are reiterating our $190 fair value estimate and narrow moat rating for the managed-care firm. UnitedHealth reported a 7.5% overall operating margin, which remained flat from year-ago levels, as a slightly lower medical loss ratio was offset by a slightly higher operating cost ratio. While the lower medical loss ratio is a positive, we expect this trend to reverse over the the next several quarters as utilization rates start to tick up due to a continuing mix shift toward higher-cost Medicare and Medicaid. For the quarter, employer- and commercial-based membership decreased 2% year over year, while Medicare/Medicaid membership increased 6% over the same time period.

From our perspective, we believe secular growth trends within the health insurance market will largely be driven by the higher-cost Medicare and Medicaid cohorts. The members that make up this risk pool tend to skew older and sicker, and thus, usually carry a materially high level of medical costs. With this shift in membership growth, we believe it’s essential for United to control its operating costs.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Vishnu Lekraj does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.